Hydroxyurea-induced dermatomyositis-like eruption.
Hydroxyurea is a cytotoxic chemotherapeutic agent used for myelodysplasia. The adverse cutaneous effects due to hydroxyurea include leg ulcers, hyperpigmentation of the skin and nails, a lichen planus-like eruption, lupus erythematosus, and a dermatomyositis-like eruption. We present a case of hydroxyurea-induced dermatomyositis-like eruption and review the features of this entity as previously reported.
Dacey
Michael J
MJ
Division of Dermatology, Department of Medicine, University of Louisville School of Medicine, Kentucky, USA.
Callen
Jeffrey P
JP
D000368:Aged; D001707:Biopsy, Needle; D003882:Dermatomyositis / Q000139:chemically induced* / Q000473:pathology*; D003875:Drug Eruptions / Q000209:etiology / Q000473:pathology*; D005260:Female; D005500:Follow-Up Studies; D006229:Hand Dermatoses / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis / Q000188:drug therapy*; D018570:Risk Assessment